Alpharma Announces First Quarter 2007 Conference Call

Alpharma Announces First Quarter 2007 Conference Call

BRIDGEWATER, N.J., April 25 /PRNewswire-FirstCall/ -- Alpharma Inc. (NYSE: ALO) announced that the company will release its first quarter 2007 earnings after the market close on Monday, April 30, 2007. Alpharma management, will conduct a conference call / webcast on Tuesday, May 1, 2007 beginning at 8:00 AM Eastern Daylight Time to discuss its first quarter results.

The call will be open to all interested parties and may be accessed by using the following information:

  CONFERENCE CALL ACCESS
  Domestic Dial In: (800) 374-0147
  International Dial In: (706) 634-5431
  Conference Call ID: 6301034

Investors can access the call in a "listen only" mode via the Internet at http://www.streetevents.com/.

In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Tuesday, May 1, 2007 at 12:00 PM Eastern Daylight Time until Tuesday, May 15, 2007 at midnight. The rebroadcast may be accessed on the Internet at http://www.streetevents.com/ or by telephone using the following information:

  REBROADCAST ACCESS
  Domestic Dial In: (800) 642-1687
  International Dial In: (706) 645-9291
  Participant Code: 6301034

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

  Contact:
  Kathleen Makrakis - VP, Investor Relations
  kathleen.makrakis@alpharma.com
  908-566-3826
Website: http://www.alpharma.com/
Website: http://www.streetevents.com/



Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.



Copyright © 1996-2003 PR Newswire Association LLC. All Rights Reserved.
A
United Business Media company.